Loading stock data…
Medpace Holdings (MEDP)
$534.72+7.65 (+1.45%)
Market ClosedLast close Jun 29
Medpace Holdings, Inc.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Medpace Holdings, Inc. in the Healthcare sector is trading at $534.72 with a market capitalization of $13.1B. Wall Street consensus targets $443.50 (12 analysts), implying a -17.1% move over the next 12 months. The stock is currently 15% below its 52-week high of $628.92, remaining 4.2% above its 200-day moving average. On fundamentals, Piotroski 6/9 shows mixed financial quality, Altman Z in the safe zone. The Whystock Score of 85/100 reflects bullish alignment across trend, valuation and analyst targets.
Ecosystem Influences
Sell-side targets imply -17.1% downside over 12 months
Long-term trend bullish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Quarterly Financials
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $706.60M↓ | $708.45M↑ | $659.90M↑ | $603.31M↑ | $558.57M |
| Gross Profit | $196.33M↓ | $205.32M↑ | $196.94M↑ | $180.01M↑ | $178.35M |
| Operating Income | $141.50M↓ | $153.27M↑ | $141.81M↑ | $126.33M↑ | $113.52M |
| Net Income | $123.87M↓ | $135.13M↑ | $111.14M↑ | $90.26M↓ | $114.59M |
Peer Comparison
JNJUNHPFE
Fundamentals
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, Asia, South America, Africa, and Australia. The company offers a suite of services supporting the clinical development proc...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$13.06B
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
-
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Elite ROE. Management converts capital into profit efficiently.
76.95%
Volume
Today's trading volume
369,406
Recent News
CON or MEDP: Which Is the Better Value Stock Right Now?
CON vs. MEDP: Which Stock Is the Better Value Option?
Medpace (MEDP) Advances While Market Declines: Some Information for Investors
Medpace (MEDP) reached $519.96 at the closing of the latest trading day, reflecting a +1.4% change compared to its last close.
2 Healthcare Stocks to Consider Right Now and 1 We Brush Off
From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. Players catalyzing medical advancements have benefited from elevated demand, which has supported the industry’s returns lately - over the past six months, healthcare stocks have gained 7.6%, nearly mirroring the S&P 500.
3 Market-Beating Stocks to Target This Week
The best-performing stocks typically have robust sales growth, increasing margins, and rising returns on capital, and those that can maintain this trifecta year in and year out often become the legends of the investing world.
What Makes Medpace Holdings (MEDP) an Investment Bet?
Turtle Creek Asset Management, an investment management company, recently published its Q1 2026 report. A copy is available to download here. Turtle Creek Asset Management’s Q1 2026 report covers key market factors currently at play. The escalation of the Iran conflict has pushed oil and gas prices higher, while AI’s impact on various sectors, especially […]